UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Peak emission wavelength and fluorescence lifetime are coupled in far-red, GFP-like fluorescent proteins

PloS one, 2018-11, Vol.13 (11), p.e0208075

2018

Volltextzugriff (PDF)

siRNA off-target effects can be reduced at concentrations that match their individual potency

PloS one, 2011-07, Vol.6 (7), p.e21503-e21503

2011

Volltextzugriff (PDF)

Biologically Relevant Heterogeneity: Metrics and Practical Insights

SLAS Discovery, 2017-03, Vol.22 (3), p.213-237

2017

Volltextzugriff (PDF)

High-Content Screening Approaches That Minimize Confounding Factors in RNAi, CRISPR, and Small Molecule Screening

Methods in molecular biology (Clifton, N.J.), 2018, Vol.1683, p.113

Haney, Steven A

2018

Volltextzugriff (PDF)

High content screening: science, techniques, and applications

Haney, Steven A

1st ed., 2008

Volltextzugriff (PDF)

Expanding the repertoire of RNA interference screens for developing new anticancer drug targets

Expert opinion on therapeutic targets, 2007-11, Vol.11 (11), p.1429-1441

Haney, Steven A

2007

Volltextzugriff (PDF)

Perspective: SBI 2 at Its Fifth Annual Meeting

Assay and drug development technologies, 2018-08, Vol.16 (6), p.291-296

Haney, Steven A.

2018

Volltextzugriff (PDF)

An introduction to high content screening: imaging technology, assay development, and data analysis in biology and drug discovery

1, 2014

Volltextzugriff (PDF)

Rapid Assessment and Visualization of Normality in High-Content and Other Cell-Level Data and Its Impact on the Interpretation of Experimental Results

Journal of biomolecular screening, 2014-06, Vol.19 (5), p.672-684

Haney, Steven A

2014

Volltextzugriff (PDF)

Transcriptional changes associated with breast cancer occur as normal human mammary epithelial cells overcome senescence barriers and become immortalized

Molecular cancer, 2007-01, Vol.6 (1), p.7-7, Article 7

2007

Volltextzugriff (PDF)

High-content screening moves to the front of the line

Drug discovery today, 2006-10, Vol.11 (19), p.889-894

2006

Volltextzugriff (PDF)

Increasing the robustness and validity of RNAi screens

Pharmacogenomics, 2007-08, Vol.8 (8), p.1037-1049

Haney, Steven A

2007

Volltextzugriff (PDF)

Interview with Steven A. Haney, PhD

Assay and drug development technologies, 2014-01, Vol.12 (1), p.12-15

2014

Volltextzugriff (PDF)

Automated Image Analysis for High-Content Screening and Analysis

Journal of biomolecular screening, 2010-08, Vol.15 (7), p.726-734

2010

Volltextzugriff (PDF)

Increased retention of functional fusions to toxic genes in new two-hybrid libraries of the E. coli strain MG1655 and B. subtilis strain 168 genomes, prepared without passaging through E. coli

BMC genomics, 2003-09, Vol.4 (1), p.36-36, Article 36

2003

Volltextzugriff (PDF)

Identification of MicroRNAs That Control Lipid Droplet Formation and Growth in Hepatocytes via High-Content Screening

Journal of biomolecular screening, 2010-08, Vol.15 (7), p.798-805

2010

Volltextzugriff (PDF)

Imaging and Analysis of 3D Tumor Spheroids Enriched for a Cancer Stem Cell Phenotype

Journal of biomolecular screening, 2010-08, Vol.15 (7), p.820-829

2010

Volltextzugriff (PDF)

Development of High-Content Imaging Assays for Lethal Viral Pathogens

Journal of biomolecular screening, 2010-08, Vol.15 (7), p.755-765

2010

Volltextzugriff (PDF)

A Personal Perspective on High-Content Screening (HCS): From the Beginning

Journal of biomolecular screening, 2010-08, Vol.15 (7), p.720-725

Taylor, D. Lansing

2010

Volltextzugriff (PDF)

Factors Affecting Reproducibility between Genome-Scale siRNA-Based Screens

Journal of biomolecular screening, 2010-08, Vol.15 (7), p.735-747

2010

Volltextzugriff (PDF)

Implementation of a 220,000-Compound HCS Campaign to Identify Disruptors of the Interaction between p53 and hDM2 and Characterization of the Confirmed Hits

Journal of biomolecular screening, 2010-08, Vol.15 (7), p.766-782

2010

Volltextzugriff (PDF)

Anticancer drug development incorporating high-content screening and RNAi: synergistic approaches to improve target identification and validation

Expert opinion on drug discovery, 2006-06, Vol.1 (1), p.19-29

Haney, Steven A

2006

Volltextzugriff (PDF)

Early Safety Assessment Using Cellular Systems Biology Yields Insights into Mechanisms of Action

Journal of biomolecular screening, 2010-08, Vol.15 (7), p.783-797

2010

Volltextzugriff (PDF)

Composite Primary Neuronal High-Content Screening Assay for Huntington’s Disease Incorporating Non-Cell-Autonomous Interactions

Journal of biomolecular screening, 2010-08, Vol.15 (7), p.806-819

2010

Volltextzugriff (PDF)

Screening Cellular Feature Measurements for Image-Based Assay Development

Journal of biomolecular screening, 2010-08, Vol.15 (7), p.840-846

2010

Volltextzugriff (PDF)

1 – 25 von 194

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(161)

Publikationsform

Sprache

Englisch
(194)

Erscheinungsjahr

n.n

Thema

Science & Technology
(115)
Life Sciences & Biomedicine
(76)
Humans
(49)
Physical Sciences
(49)
Chemistry
(44)
Chemistry, Analytical
(42)
Biochemistry & Molecular Biology
(26)
Biotechnology & Applied Microbiology
(22)
Biochemical Research Methods
(21)
Animals
(20)
Chemistry, Applied
(20)
Biological And Medical Sciences
(17)
Male
(17)
High-Content Screening
(14)
High-Throughput Screening Assays - Methods
(14)
Female
(12)
Cell Line, Tumor
(10)
Medical Sciences
(10)
Middle Aged
(10)
Rna Interference
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Peak emission wavelength and fluorescence lifetime are coupled in far-red, GFP-like fluorescent proteins

siRNA off-target effects can be reduced at concentrations that match their individual potency

Biologically Relevant Heterogeneity: Metrics and Practical Insights

High-Content Screening Approaches That Minimize Confounding Factors in RNAi, CRISPR, and Small Molecule Screening

High content screening: science, techniques, and applications

Expanding the repertoire of RNA interference screens for developing new anticancer drug targets

Perspective: SBI 2 at Its Fifth Annual Meeting

An introduction to high content screening: imaging technology, assay development, and data analysis in biology and drug discovery

Rapid Assessment and Visualization of Normality in High-Content and Other Cell-Level Data and Its Impact on the Interpretation of Experimental Results

Transcriptional changes associated with breast cancer occur as normal human mammary epithelial cells overcome senescence barriers and become immortalized

High-content screening moves to the front of the line

Increasing the robustness and validity of RNAi screens

Interview with Steven A. Haney, PhD

Automated Image Analysis for High-Content Screening and Analysis

Increased retention of functional fusions to toxic genes in new two-hybrid libraries of the E. coli strain MG1655 and B. subtilis strain 168 genomes, prepared without passaging through E. coli

Identification of MicroRNAs That Control Lipid Droplet Formation and Growth in Hepatocytes via High-Content Screening

Imaging and Analysis of 3D Tumor Spheroids Enriched for a Cancer Stem Cell Phenotype

Development of High-Content Imaging Assays for Lethal Viral Pathogens

A Personal Perspective on High-Content Screening (HCS): From the Beginning

Factors Affecting Reproducibility between Genome-Scale siRNA-Based Screens

Implementation of a 220,000-Compound HCS Campaign to Identify Disruptors of the Interaction between p53 and hDM2 and Characterization of the Confirmed Hits

Anticancer drug development incorporating high-content screening and RNAi: synergistic approaches to improve target identification and validation

Early Safety Assessment Using Cellular Systems Biology Yields Insights into Mechanisms of Action

Composite Primary Neuronal High-Content Screening Assay for Huntington’s Disease Incorporating Non-Cell-Autonomous Interactions

Screening Cellular Feature Measurements for Image-Based Assay Development

Suchergebnisse filtern